Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR

RNA

Volumn 13, Issue 6, 2007, Pages 890-898

  Wing, Pui Tsang ^a   Wong, Timothy W L ^a   Cheung, Albert H H ^a   Co, Chloe N N ^a   Tim, Tak Kwok ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Caspase 3; Cellular transformation; CUDR; Drug resistance; ncRNA

Indexed keywords

CASPASE 3; DOXORUBICIN; ETOPOSIDE; UNTRANSLATED RNA;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER RESISTANCE; CANCER UP REGULATED DRUG RESISTANT GENE; CELL LYSATE; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; DNA SEQUENCE; DOWN REGULATION; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION; SEQUENCE HOMOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR GENE; WESTERN BLOTTING;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 19; DNA, COMPLEMENTARY; DNA, NEOPLASM; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENES; RNA, UNTRANSLATED; TRANSFECTION;

EID: 34249014622     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.359007     Document Type: Article

References (21)

1. Cole, S.P. and Deeley, R.G. 1995. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP. Bioessays 20: 931-940.
2. Devarajan, E., Sahin, A.A., Chen, J.S., Krishnamurthy, R.R., Aggarwal, N., Brun, A.M., Sapino, A., Zhang, F., Sharma, D., Yang, X.H., et al. 2002. Down-regulation of caspase 3 in breast cancer: A possible mechanism for chemoresistance. Oncogene 21: 8843-8851.
3. Eddy, S.R. 2001. Noncoding RNA genes and the modern RNA world. For. Genet. 2: 919-929.
4. Erdmann, V.A., Barciszewska, M.Z., Hochberg, A., de Groot, N., and Barciszewski, J. 2001. Regulatory RNAs. Cell. Mol. Life Sci. 58: 960-977.
5. Fire, A., Xu, S., Montomery, M.K., Kostas, S.A., Driver, S.E., and Mello, C.C. 1998. Potent and specific genetic interference by doublestranded RNA in Caenorhabditis elegans. Nature 391: 806-811.
6. Fojo, T. and Bates, S. 2003. Strategies for reversing drug resistance. Oncogene 22: 7512-7523.
7. Fong, P.Y., Xue, W.C., Ngan, H.Y., Chiu, P.M., Chan, K.Y., Tsao, S.W., and Cheung, A.N. 2006. Caspase activity is down-regulated in choriocarcinoma: A cDNA array differential expression study. J. Clin. Pathol. 59: 179-183.
8. Hurst, L.D. and Smith, N.G.C. 1999. Molecular evolutionary evidence that H19 mRNA is functional. Trends Genet. 15: 134-135.
9. Jaattela, M. 2004. Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene 23: 2746-2756.
10. Kwok, T.T. and Sutherland, R.M. 1991. Epidermal growth factor reduces resistance to doxorubicin. Int. J. Cancer 49: 73-76.
11. Lage, H., Helmbach, H., Dietel, M., and Schadendort, D. 2000. Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance. Br. J. Cancer 82: 488-491.
12. Lindbo, J.A., Silva-Rosales, L., Proebsting, W.M., and Dougherty, W.G. 1993. Induction of a highly specific antiviral state in transgenic plants: Implications for regulation of gene expression and virus resistance. Plant Cell 5: 1749-1759.
13. Miyashiro, K.Y., Beckel-Mitchener, A., Purk, T.P., Becker, K.G., Barret, T., Liu, L., Carbonetto, S., Weiler, I.J., Greenough, W.T., and Eberwine, J. 2003. RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron 37: 417-431.
14. Montgomery, M.K., Xu, S., and Fire, A. 1998. RNA as a target of double-stranded RNA-mediated genetic interference in caenorhabditis elegans. Proc. Natl. Acad. Sci. 95: 15502-15507.
15. Okazaki, Y., Furuno, M., Kasukawa, T., Adachi, J., Bono, H., Kondo, S., Nikaido, I., Osato, N., Saito, R., Suzuki, H., et al. 2002. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature 420: 563-573.
16. Szakacs, G., Paterson, J.K., Ludwig, J.A., Booth-Genthe, C., and Gottesman, M.M. 2006. Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov. 5: 219-234.
17. Vernucci, M., Cerrato, F., Pedone, P.V., Dandolo, L., Bruni, C.B., and Riccio, A. 2004. The 5′ end of the KCNQ1OT1 gene is hypomethylated in the Beckwith-Wiedemann syndrome. Hum. Mol. Genet. 13: 353-361.
18. Wang, X.S., Zhang, Z., Wang, H.C., Cai, J.L., Xu, Q.W., Li, M.Q., Chen, Y.C., Qian, X.P., Lu, T.J., Yu, L.Z., et al. 2006. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin. Cancer Res. 12: 4851-4858.
19. Winter, R.N., Kramer, A., Borkowski, A., and Kyprianou, N. 2001. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res. 16: 1227-1232.
20. Yang, X.H., Sladek, T.L., Liu, X., Butler, B.R., Froelich, C.J., and Thor, A.D. 2001. Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Cancer Res. 61: 348-354.
21. Yang, X.H., Edgerton, S., and Thor, A.D. 2005. Reconstitution of caspase-3 sensitizes MCF-7 breast cancer cells to radiation therapy. Int. J. Oncol. 26: 1675-1680.